Independent clinical trial management organization, FutureMeds, has appointed Dr. Piotr Rozpondek, as Managing Director of FutureMeds Poland

FutureMeds bolsters their position in top tier of Dedicated Research Site Networks in Central and Eastern Europe by expanding into Ukraine

FutureMeds’ Ukraine will increase trial awareness, improve trial efficiency and extend opportunities in the country.

Prof. Dr. Borislav Borissov, MD, MBA, DSc, will be responsible for leading FutureMeds’ Bulgarian operations.

Almost all FDA approved osteoporosis medications have been investigated by FutureMeds’ Senior Medical Director, Prof. E. Czerwinski MD PhD

FutureMeds has completed a refinancing underpinned with investment from dealspan, a UK-based independent boutique investment firm

By the end of the year, FutureMeds plans to operate from 3 sites located in the biggest cities in Bulgaria

FutureMeds expands its network and partners with Medeusz-Plus, a renowned cardiovascular clinic in Olsztyn, northern Poland.

FutureMeds moves into the top tier of Dedicated Site Networks in Central and Eastern Europe.

FutureMeds presence in the U.K. and our network of medical research clinics will unlock an accelerated, 4 times more efficient trial process

FutureMeds are delighted to announce the acquisition of KCM, a leading clinical trial site based in Krakow, Poland. KCM was founded in...

We are extremely proud to welcome Christophe Berthoux as Chairman of FutureMeds and are excited to bring his vast amount of global...

FutureMeds, a UK based Dedicated Research Sites Network announces the appointment of Dr Radoslaw Janiak as its Chief Executive Officer....

FutureMeds, a new independent Site Management Organisation, has opened its first site in Wroclaw, Poland.  The site is the first of a...